Related Experiment Videos

[Effect of systemic thrombolytic therapy on clinico-hemodynamic indicators in patients with acute myocardial

N B Perepech, A O Nedoshivin, A L Makedonov

    Klinicheskaia Meditsina
    |January 1, 1991
    PubMed

    Insights

    Systemic thrombolytic therapy reduces risks of left ventricular failure and arrhythmias in acute myocardial infarction patients. This treatment preserves left ventricular contractility during the infarction

    Area of Science:

    • Cardiology
    • Internal Medicine

    Context:

    • Acute myocardial infarction (AMI) management.
    • Evaluating the impact of systemic thrombolytic therapy.

    Purpose:

    • To investigate the effects of systemic thrombolytic therapy on left ventricular contractility, central hemodynamics, and clinical outcomes in AMI patients.
    • To compare these effects against a control group.

    Summary:

    • Systemic thrombolytic therapy was administered to inpatients with acute myocardial infarction.
    • The therapy demonstrated a significant reduction in the risk of acute left ventricular failure, ventricular fibrillation, and atrioventricular block.
    • Crucially, it prevented the inhibition of left ventricular contractility during the acute phase of infarction.
    • Over time, the observed differences in contractility and hemodynamics between the treated group and controls diminished.

    Impact:

    • Provides evidence for the protective role of thrombolytic therapy in preserving cardiac function post-myocardial infarction.
    • Highlights the short-term benefits of thrombolysis in mitigating immediate complications.
    • Suggests that early intervention with thrombolysis can improve acute cardiac performance.

    Related Concept Videos